Fast and sensitive quantitative detection of HIV DNA in whole blood leucocytes by SYBR green I real-time PCR assay

Molecular and Cellular Probes

Volumn 21, Issue 5-6, 2007, Pages 368-378

  Casabianca, Anna ^a   Gori, Caterina ^b   Orlandi, Chiara ^a   Forbici, Federica ^b   Federico Perno, Carlo ^b   Magnani, Mauro ^a  

^a UNIVERSITY OF URBINO   (Italy)

^b NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

Author keywords

HIV DNA quantification; Human endogenous retroviruses; Primer binding site; SYBR Green I real time PCR; Whole blood leucocytes

Indexed keywords

ANTIRETROVIRUS AGENT; FLUORESCENT DYE; PRIMER DNA; SYBR GREEN 1; UNCLASSIFIED DRUG; VIRUS DNA;

ARTICLE; BLOOD SAMPLING; DNA BINDING; DNA DETERMINATION; DNA EXTRACTION; DNA SEQUENCE; GENETIC CONSERVATION; GROUP SPECIFIC ANTIGEN GENE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOUSEKEEPING GENE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEUKOCYTE; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PURIFICATION; REAL TIME POLYMERASE CHAIN REACTION; VIREMIA; VIRUS DETECTION; VIRUS GENE;

BINDING SITES; DNA PRIMERS; DNA, VIRAL; HIV-1; HUMANS; LEUKOCYTES; ORGANIC CHEMICALS; REFERENCE STANDARDS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TIME FACTORS; VIRAL LOAD;

HUMAN ENDOGENOUS RETROVIRUSES; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 34547898048     PISSN: 08908508     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcp.2007.05.005     Document Type: Article

References (45)

1. Pierson T., McArthur J., and Siliciano R.F. Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy. Annu Rev Immunol 18 (2000) 665-708
2. Blankson J.N., Persaud D., and Siliciano R.F. The challenge of viral reservoirs in HIV-1 infection. Annu Rev Med 53 (2002) 557-593
3. Chun T.W., Nickle D.C., Justement J.S., Large D., Semerjian A., Curlin M.E., et al. HIV-infected individuals receiving effective antiviral therapy for extended periods of time continually replenish their viral reservoir. J Clin Invest 115 (2005) 3250-3255
4. Bailey J.R., Sedaghat A., Kieffer T., Brennan T., Lee P.K., Wind-Rotolo M., et al. Residual human immunodeficiency virus type 1 viremia in some patients on antiretroviral therapy is dominated by a small number of invariant clones rarely found in circulating CD4+ T cells. J Virol 80 (2006) 6441-6457
5. Hammer S.M., Saag M.S., Schechter M., Montaner J.S., Schooley R.T., Jacobsen D.M., et al. Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel. JAMA 296 (2006) 827-843
6. Viard J.P., Burgard M., Hubert J.B., Aaron L., Rabian C., Pertuiset N., et al. Impact of 5 years of maximally successful highly active antiretroviral therapy on CD4 cell count and HIV-1 DNA level. AIDS 18 (2004) 45-49
7. Rouzioux C., Hubert J.B., Burgard M., Deveau C., Goujard C., Bary M., et al. SEROCO Cohort Study Group. Early levels of HIV-1 DNA in peripheral blood mononuclear cells are predictive of disease progression independently of HIV-1 RNA levels and CD4+ T cell counts. J Infect Dis 192 (2005) 46-55
8. Goujard C., Bonarek M., Meyer L., Bonnet F., Chaix M.L., Deveau C., et al. Agence Nationale de Recherche sur le Sida PRIMO Study Group. CD4 cell count and HIV DNA level are independent predictors of disease progression after primary HIV type 1 infection in untreated patients. Clin Infect Dis 42 (2006) 709-715
9. Christopherson C., Kidane Y., Conway B., Krowka J., Sheppard H., and Kwok S. PCR-Based assay to quantify human immunodeficiency virus type 1 DNA in peripheral blood mononuclear cells. J Clin Microbiol 38 (2000) 630-634
10. Marchetti G., Gori A., Casabianca A., Magnani M., Pranzetti F., Clerici M., et al. Comparative analysis of T-cell turnover and homeostatic parameters in HIV-infected patients with discordant immune-virological responses to HAART. AIDS 20 (2006) 1727-1736
11. Yerly S., Gunthard H.F., Fagard C., Joos B., Perneger T.V., Hirschel B., et al. Swiss HIV Cohort Study. Proviral HIV-DNA predicts viral rebound and viral setpoint after structured treatment interruptions. AIDS. 18 (2004) 1951-1953
12. Shiramizu B., Gartner S., Williams A., Shikuma C., Ratto-Kim S., Watters M., et al. Circulating proviral HIV DNA and HIV-associated dementia. AIDS 19 (2005) 45-52
13. Shiramizu B., Ratto-Kim S., Sithinamsuwan P., Nidhinandana S., Thitivichianlert S., Watt G., et al. HIV DNA and dementia in treatment-naive HIV-1-infected individuals in Bangkok, Thailand. Int J Med Sci 4 (2006) 13-18
14. Shehu-Xhilaga M., Tachedjian G., Crowe S.M., and Kedzierska K. Antiretroviral compounds: mechanisms underlying failure of HAART to eradicate HIV-1. Curr Med Chem 12 (2005) 1705-1719
15. Marcello A. Latency: the hidden HIV-1 challenge. Retrovirology 2006. doi:10.1186/1742-4690-3-7.
16. Celum C.L., Coombs R.W., Jones M., Murphy V., Fisher L., Grant C., et al. Risk factors for repeatedly reactive HIV-1 EIA and indeterminate western blots. A population-based case-control study. Arch Intern Med 154 (1994) 1129-1137
17. Ling A.E., Robbins K.E., Brown T.M., Dunmire V., Thoe S.Y., Wong S.Y., et al. Failure of routine HIV-1 tests in a case involving transmission with preseroconversion blood components during the infectious window period. JAMA 284 (2000) 210-214
18. Comar M., Simonelli C., Zanussi S., Paoli P., Vaccher E., Tirelli U., et al. Dynamics of HIV-1 mRNA expression in patients with long-term nonprogressive HIV-1 infection. J Clin Invest 100 (1997) 893-903
19. McDermott J.L., Giri A.A., Martini I., Bono M., Giacobini M., Campelli A., et al. Level of human immunodeficiency virus DNA in peripheral blood mononuclear cells correlates with efficacy of antiretroviral therapy. J Clin Microbiol 37 (1999) 2361-2365
20. Debiaggi M., Zara F., Pistorio A., Bruno R., Sacchi P., Patrono S.F., et al. Quantification of HIV-1 proviral DNA in patients with undetectable plasma viremia over long-term highly active antiretroviral therapy. Int J Infect Dis 4 (2000) 187-193
21. Tierney C., Lathey J.L., Christopherson C., Bettendorf D.M., D'Aquila R.T., Hammer S.M., et al. Prognostic value of baseline human immunodeficiency virus type 1 DNA measurement for disease progression in patients receiving nucleoside therapy. J Infect Dis 187 (2003) 144-148
22. Désiré N., Dehée A., Schneider V., Jacomet C., Goujon C., Girard P.M., et al. Quantification of human immunodeficiency virus type 1 proviral load by a TaqMan real-time PCR assay. J Clin Microbiol 39 (2001) 1303-1310
23. Kostrikis L.G., Touloumi G., Karanicolas R., Pantazis N., Anastassopoulou C., Karafoulidou A., et al. The Multicenter Hemophilia Cohort Study Group. Quantitation of human immunodeficiency virus type 1 DNA forms with the second template switch in peripheral blood cells predicts disease progression independently of plasma RNA load. J Virol 76 (2002) 10099-10108
24. Eriksson L.E., Leitner T., Wahren B., Bostrom A.C., and Falk K.I. A multiplex real-time PCR for quantification of HIV-1 DNA and the human albumin gene in CD4+ cells. APMIS 111 (2003) 625-633
25. Gibellini D., Vitone F., Schiamone P., Ponti C., La Placa M., and Re M.C. Quantitative detection of human immunodeficiency virus type 1 (HIV-1) proviral DNA in peripheral blood mononuclear cells by SYBR green real-time PCR technique. J Clin Virol 29 (2004) 282-289
26. Kabamba-Mukadi B, Henrivaux P, Ruelle J, Del ferriere N, Bodeus M, Goubau P, Human immunodeficiency virus type 1 (HIV-1) proviral DNA load in purified CD4+ cells by LightCycler real-time PCR BMC. Infect Dis 2005. doi:10.1186/1471-2334-5-15.
27. Beck I.A., Drennan K.D., Melvin A.J., Mohan K.M., Herz A.M., Alarcon J., et al. Simple, sensitive, and specific detection of human immunodeficiency virus type 1 subtype B DNA in dried blood samples for diagnosis in infants in the field. J Clin Microbiol 39 (2001) 29-33
28. Luo W., Yang H., Rathbun K., Pau C.P., and Ou C.Y. Detection of human immunodeficiency virus type 1 DNA in dried blood spots by a duplex real-time PCR assay. J Clin Microbiol 43 (2005) 1851-1857
29. Gao F., Robertson D.L., Carruthers C.D., Morrison S.G., Jian B., Chen Y., et al. A comprehensive panel of near-full-length clones and reference sequences for non-subtype B isolates of human immunodeficiency virus type 1. J Virol 72 (1998) 5680-5698
30. Casabianca A., Orlandi C., Fraternale A., and Magnani M. Development of a real-time PCR assay using SYBR Green I for provirus load quantification in a murine model of AIDS. J Clin Microbiol 42 (2004) 4361-4364
31. Gregory TR. 2007. Animal Genome Size Database 〈http://www.genomesize.com〉.
32. Rhim H., Park J., and Morrow C.D. Deletions in the tRNA(Lys) primer-binding site of human immunodeficiency virus type 1 identify essential regions for reverse transcription. J Virol 65 (1991) 4555-4564
33. Kaushik N., Talele T.T., Monel R., Palumbo P., and Pandey V.N. Destabilization of tRNA3(Lys) from the primer-binding site of HIV-1 genome by anti-A loop polyamide nucleotide analog. Nucleic Acids Res 29 (2001) 5099-5106
34. Eberhardy S.R., Goncalves J., Coelho S., Segal D.J., Berkhout B., and Barbas III C.F. Inhibition of human immunodeficiency virus type 1 replication with artificial transcription factors targeting the highly conserved primer-binding site. J Virol 80 (2006) 2873-2883
35. Wu X., Li Y., Crise B., and Burgess S.M. Transcription start regions in the human genome are favored targets for MLV integration. Science 300 (2003) 1749-1751
36. Leitner T., Foley B., Hahn B., Marx P., McCutchan F., Mellors J., et al. HIV sequence compendium 2005 (2005), Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, N. Mex
37. Karsai A., Muller S., Platz S., and Hauser M.T. Evaluation of a home-made SYBR green I reaction mixture for real-time PCR quantification of gene expression. Biotechniques 32 (2002) 790-796
38. Griffiths DJ. Endogenous retroviruses in the human genome sequence. Genome Biol 2001. doi:10.1186/gb-2001-2-6-reviews1017.
39. Yi J.M., Kim H.M., and Kim H.S. Expression of the human endogenous retrovirus HERV-W family in various human tissues and cancer cells. J Gen Virol 85 (2004) 1203-1210
40. Bannert N., and Kurth R. The evolutionary dynamics of human endogenous retroviral families. Annu Rev Genomics Hum Genet 7 (2006) 149-173
41. User Bulletin No. 2, ABI Prism 7700 Sequence Detection System, December 11, 1997. Foster City: Applied Biosystems.
42. Locatelli G., Santoro F., Veglia F., Gobbi A., Lusso P., and Malnati M.S. Real-time quantitative PCR for human herpesvirus 6 DNA. J Clin Microbiol 38 (2000) 4042-4048
43. Nagashunmugam T., Velpandi A., Goldsmith C.S., Zaki S.R., Kalyanaraman V.S., and Srinivasan A. Mutation in the primer binding site of the type 1 human immunodeficiency virus genome affects virus production and infectivity. Proc Natl Acad Sci. USA 89 (1992) 4114-4118
44. Furtado M.R., Callaway D.S., Phair J.P., Kunstman K.J., Stanton J.L., Macken C.A., et al. Persistence of HIV-1 transcription in peripheral-blood mononuclear cells in patients receiving potent antiretroviral therapy. N Engl J Med 340 (1999) 1614-1622
45. Zhao Y., Yu M., Miller J.W., Chen M., Bremer E.G., Kabat W., et al. Quantification of human immunodeficiency virus type 1 proviral DNA by using TaqMan technology. J Clin Microbiol 40 (2002) 675-678